A note on hypothesis test in binary data under the single-consent randomized design

Drug Information Journal

Volumn 40, Issue 2, 2006, Pages 219-227

  Lui, Kung Jong ^a  

^a SAN DIEGO STATE UNIVERSITY   (United States)

Author keywords

Efficiency; Power; Prerandomized design; Simple compliance study; Type I error

Indexed keywords

RETINOL;

CHILDHOOD MORTALITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DRUG DESIGN; EVALUATION RESEARCH; EXPERIMENTAL THERAPY; HUMAN; HYPOTHESIS; INFORMED CONSENT; INTENTION TO TREAT ANALYSIS; INTERMETHOD COMPARISON; MATHEMATICAL ANALYSIS; MONTE CARLO METHOD; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SINGLE CONSENT RANDOMIZED DESIGN; VITAMIN SUPPLEMENTATION;

EID: 33646593796     PISSN: 00928615     EISSN: None     Source Type: Journal    
DOI: 10.1177/009286150604000211     Document Type: Review

References (21)

1. Zelen M. A new design for randomized clinical trials. N Engl J Med. 1979;300:1242-1245.
2. Zelen M. Randomized consent designs for clinical trials: an update. Stat Med. 1990;9: 645-656.
3. O'Rourke PP, Crone RK, Vacanti JP, et al. A prospective randomized study of extracorporeal membrane oxygenation (ECMO) and conventional medical therapy in neonates with persistent pulmonary hypertension of the newborn. Pediatrics 1989;84:957-963.
4. Sommer A, Zeger SL. On estimating efficacy from clinical trials. Stat Med 1991;10:45-52.
5. Sommer A, Tarwotjo I, Djunaedi E, et al. Impact of vitamin A supplementation on childhood mortality: a randomized controlled community trial. Lancet 1986;1:1169-1173.
6. Zelen M. Response. J Chronic Dis. 1986;39:247-249.
7. Bernhard G, Compagnone D. Binary data in pre-randomized designs. Biometric J. 1989;31:29-33.
8. Anbar D. The relative efficiency of Zelen's prerandomization design for clinical trials. Biometrics 1983;39:711-718.
9. McHugh R. Validity and treatment dilution in Zelen's single consent design. Stat Med. 1984;3: 215-218.
10. Matts J, McHugh R. Randomization and efficiency in Zelen's single consent design. Biometrics 1987;43:885-894.
11. Matts JP, McHugh RB. Precision estimation in Zelen's single-consent design. Biometrical J. 1993; 35:65-72.
12. Brunner E, Neumann N. On the mathematical basis of Zelen's prerandomized designs. Methods Inf Med. 1985;24:120-130.
13. Ellenberg SS. Randomization designs in comparative clinical trials. N Engl J Med. 1984;310: 1404-1408.
14. Lui K-J, Lin C-D. Interval estimation of treatment effects in double consent randomized design. Stat Sin. 2003;13:179-187.
15. Lin C-D, Lui K-J. Randomized consent designs for clinical trials: an update [letter to the editor]. Stat Med. 2002;21:2601-2603.
16. Casella G, Berger RL. Statistical Inference. Belmont, CA: Duxbury; 1990.
17. Sato T. Sample size calculations with compliance information. Stat Med. 2000;19:2689-2697.
18. Fleiss J. Statistical Methods for Rates and Proportions, 2nd ed. New York: Wiley; 1981.
19. Edwardes MD. A confidence interval for Pr(X < Y) - P(X > Y) estimated from simple cluster samples. Biometrics 1995;51:571-578.
20. Lui K-J. Notes on estimation of the general odds ratio and the general risk difference for paired-sample data. Biometric J. 2002;44:957-968.
21. SAS Institute. SAS Language, Reference Version 6. Gary, NCSAS Institute; 1990.